Protagonist Therapeutics Inc (PTGX)
Deferred Revenue
$9.66M
Quarterly · Period ending: · USD
PTGX Deferred Revenue
Latest reported$9.66Mperiod ending
Latest reported$9.66Mperiod ending
PTGX Quarterly Deferred Revenue ($0.00 → $9.66M)
Quarterly deferred revenue
High-resolution chart · PNG
PTGX deferred revenue history
Quarterly · USD. Dates are reporting period ends; fiscal years can differ from calendar years.
| Period ending | Deferred Revenue (USD) |
|---|---|
| 9,659,000 | |
| 6,282,000 | |
| 9,550,000 | |
| 14,200,000 | |
| 14,688,000 | |
| 16,895,000 | |
| 18,891,000 | |
| 19,696,000 | |
| 20,124,000 | |
| 16,128,000 | |
| 0 | |
| 3,000 | |
| 10,000 | |
| 22,000 | |
| 69,000 | |
| 32,000 | |
| 80,000 | |
| 1,148,000 | |
| 2,500,000 | |
| 3,362,000 | |
| 13,405,000 | |
| 12,591,000 | |
| 17,209,000 | |
| 18,842,000 | |
| 18,233,000 | |
| 19,746,000 | |
| 19,000,000 | |
| 17,498,000 | |
| 18,527,000 | |
| 8,212,000 | |
| 8,223,000 | |
| 8,734,000 | |
| 13,478,000 | |
| 22,259,000 | |
| 31,752,000 | |
| 41,739,000 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 |